Trending News
News
News
HYD Receives Approval for Phase 2 Clinical Trial
Company has received approval by the SIDC for Phase 2 clinical trial to prove the anticancer effect of deuterium-depleted water in CLL.
News
Toxic Alzheimer's protein spreads through brain via extracellular space
Neural activity accelerates its spread through the brain.
News
Optical magnetic field sensor can detect signals from the nervous system
Quantum physics: The human body is controlled by electrical impulses in, for example, the brain, the heart and nervous system. These electrical signals create tiny magnetic fields, which doctors could use to diagnose various diseases, for example diseases of the brain or heart problems in young foetuses.
News
'Poison Pill' Fed to Deadly Virus
Researchers have created a genetic modification within a virus (with funny name), rendering it unable to replicate, mutate or cause illness.
News
T2 Biosystems Ink R&D Collaboration with Bayer
T2 Biosystems and Bayer in R&D collaboration to advance drug monitoring and biomarker discovery with a blood coagulation disorder focus.
News
Improving Tumour Therapy with Nanoparticles
UHN nanoparticle called PEARLs is a promising utilisation of photo-thermal therapy for cancer treatment.
News
'Antigen-Presenting Cell' Defends Against Cancer
Through advanced imaging, researchers have identified cells that encourages increases in immune system cancer defences.
News
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
News
ViroCyt Acquired by Sartorius
Sartorius has acquired U.S. start-up ViroCyt, expanding their bioanalytical division and reducing time of R&D and pharmaceutical production.
News
Identifying Cancer Drug Targets Using 3D-Modelling
Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
Advertisement